18F-Florbetapir PET in Primary Cerebral Amyloidoma
- PMID: 32796236
- DOI: 10.1097/RLU.0000000000003214
18F-Florbetapir PET in Primary Cerebral Amyloidoma
Abstract
Amyloid deposition can lead to Alzheimer disease and cerebral amyloid angiopathy. Rarely, it presents as a solitary focal deposition, primary cerebral amyloidoma, which can be misinterpreted as a neoplasm because of the "tumor-like" appearances. We present the case of a 54-year-old woman where MRI revealed a T2-hyperintense mass periventricular in the white matter with moderate contrast enhancement. Pathological investigation revealed AL (lambda) amyloidoma. F-florbetapir PET/CT was used to support the diagnosis and in follow-up. This case highlights that F-florbetapir PET/CT might play a role in the diagnostic workup of patients suggestive of cerebral amyloidoma, especially in cases where biopsy is not feasible.
References
-
- Gandhi D, Wee R, Goyal M. CT and MR imaging of intracerebral amyloidoma: case report and review of the literature. AJNR Am J Neuroradiol. 2003;24:519–522.
-
- Landau D, Avgeropoulos N, Ma J. Cerebral amyloidoma mimicking intracranial tumor: a case report. J Med Case Reports. 2010;4:308.
-
- Miller-Thomas MM, Sipe AL, Benzinger TL, et al. Multimodality review of amyloid-related diseases of the central nervous system. Radiographics. 2016;36:1147–1163.
-
- Saltykow S. Zur Frage des lokalen Amyloids der Hirngefäße. Virchows Arch Pathol Anat Physiol Klin Med. 1935;295:590–590.
-
- Hess K, Purrucker J, Hegenbart U, et al. Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course. Brain Pathol. 2018;28:234–239.